Charles River Laboratories International Inc
PRA Health Sciences is a leading global contract research organization. PRA raised $306 million in its initial public offering in November last year.
Market Overview Growth Drivers Appear Secular, Not Cyclical In general, CRO revenue growth is driven by three market-wide factors. First, as providers of clinical trials services, CROs are directly tied to R&D budgets among biopharmaceutical clients. Overall R&D budgets have been growing in the low-single digit range. Second, the percentage of clinical trials services performed […]